These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23675254)

  • 1. Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy.
    Liu W; Zhang J; Ying C; Wang Q; Yan C; Jingyue Y; Zhaocai Y; Yan X; Heng-Jun S; Lin J
    Int J Biomed Sci; 2012 Mar; 8(1):28-35. PubMed ID: 23675254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
    Li N; Jin ZL; Liu ZJ; Wang J; Li K
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
    Zhang L; Li N; Xu F; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].
    Sun Q; Hua J; Hang X; Mao Y; Wang Q
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):451-3. PubMed ID: 21205532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non-small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials.
    Wang CQ; Zheng XT; Chen XF; Jiang H; Huang J; Jiang Y; Hu SS; Huang XR; Liu SY; Gong QH; Feng JH; Xiao X; Li XF; Xiao Z
    Front Pharmacol; 2021; 12():582447. PubMed ID: 34122057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Randomized clinical trial of paclitaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer].
    Gou H; Chen X; Hou M; Yang Y
    Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):141-3. PubMed ID: 21114939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.
    Yang J; Zhu X; Yuan P; Liu J; Wang B; Wang G
    Support Care Cancer; 2020 Aug; 28(8):3571-3579. PubMed ID: 32266566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].
    Zhao Y; Chen Y; Ji H; Chu T; Han B; Liao M
    Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):449-51. PubMed ID: 21244803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
    von Pawel J; von Roemeling R; Gatzemeier U; Boyer M; Elisson LO; Clark P; Talbot D; Rey A; Butler TW; Hirsh V; Olver I; Bergman B; Ayoub J; Richardson G; Dunlop D; Arcenas A; Vescio R; Viallet J; Treat J
    J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of gemcitabine and cisplatin as first-line therapy in advanced non-small-cell lung cancer.
    Lee NS; Byun JH; Bae SB; Kim CK; Lee KT; Park SK; Won JH; Hong DS; Park HS
    Cancer Res Treat; 2004 Jun; 36(3):173-7. PubMed ID: 20396540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of GP regimen and Kanglaite in the treatment of advanced non-small cell lung cancer].
    Lian Z; Lu Y; Hou E; Wang X
    Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):74-7. PubMed ID: 21144288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Giaccone G; Splinter TA; Debruyne C; Kho GS; Lianes P; van Zandwijk N; Pennucci MC; Scagliotti G; van Meerbeeck J; van Hoesel Q; Curran D; Sahmoud T; Postmus PE
    J Clin Oncol; 1998 Jun; 16(6):2133-41. PubMed ID: 9626213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
    Miyanaga A; Kubota K; Hosomi Y; Okuma Y; Minato K; Fujimoto S; Okamoto H; Satouchi M; Isobe H; Aono H; Takiguchi Y; Gemma A;
    Jpn J Clin Oncol; 2019 Aug; 49(8):749-754. PubMed ID: 31070750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer.
    Ai D; Guan Y; Liu XJ; Zhang CF; Wang P; Liang HL; Guo QS
    Onco Targets Ther; 2016; 9():5693-5698. PubMed ID: 27695347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].
    Gao JF; Zhang XH; Wang J; Rao ZG; Zhu YZ; Ou WL; Zhang BC; Du GZ
    Ai Zheng; 2005 Aug; 24(8):990-3. PubMed ID: 16086879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
    Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
    Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of efficacy between GP and NP regimens in the treatment of advanced non-small cell lung cancer].
    Tian L; Wang Z; Liu D
    Zhongguo Fei Ai Za Zhi; 2002 Dec; 5(6):432-4. PubMed ID: 21333224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of combined gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer].
    Zhang Y; Hu S; Bian Z; Liang H
    Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):230-2. PubMed ID: 21190627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness study of single high-dose cisplatin with fractionated doses cisplatin in first-line therapy for treatment-naive Chinese patients with advanced non-small-cell lung cancer.
    Li X; Zhao X; Abbas M; Wang L; Li C; Liu S; Feng J; Shi M
    Curr Probl Cancer; 2019 Dec; 43(6):100466. PubMed ID: 30777344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.